Please enable JS

DISCOVER

Telemedicine technologies

Our story,
our strength

Telemedicine Technologies is the publisher of e-Health solutions, market leader in the field of Clinical Research with its CleanWeb™ solution, a secure Internet platform dedicated to the electronic management of clinical trials and registries.

For over 20 years, our company has been working to facilitate clinical research and empower all kind of clinical trials all around the world. Our solution CleanWeb™ for the electronic management of phase I-IV clinical trials, registries, observational studies and early access programmes is used in more than 64 different countries, more than 5,500 studies are ongoing or have been completed on our e-platform and more than 2 million patients have already been recruited via our solution. 



From leading pharmaceutical companies to biotech start-ups and public hospitals, we are proud to support the activities of over 20,000 investigative centres and 50,000 users worldwide.

Our CleanWeb solution is ISO9001:2015 certified and compliant with the GAMP5 information system validation methodology. CDISC/ODM certified, we have been a global expert in data management for 20 years.

Our solution has an extremely high adoption rate, thanks to intuitive interfaces and our commitment to creating solutions tailored to our users’ needs. We have Qualiopi certification for training, a distinction that testifies to our constant concern for quality and customer satisfaction. In 2021 our training courses had an excellent customer satisfaction rate of 97%.

OUR TEAM

YOANNI TH. MATSAKIS
President

He is an aeronautical and space engineer (Sup’aéro), and worked for CNES (Centre National des Etudes Spatiales) and then for the MEDES (Institut de Médecine & Physiologie Spatiales), where he joined the project team of several manned space missions as Scientific and Responsible for the development of on board equipment for the astronauts physiological follow-up. Then he launched an important research and development program, which results in the creation of the company in 2000.

HUGUES GOURBAT
CEO

He is graduated from the Ecole Centrale Paris and the Business Administration Institute of the Paris University, and is a former Accenture partner. He joined the company in 2016 during the merger of TRIACYS. As General Director, he is an Executive Committee member and is responsible for the administrative, financial and human resources management.

DR. PHILIPPE HARAN
CEO and Business Development Director

Doctor, HEC graduate, Philippe brings the company his double skills. After a career in the pharmaceutical industry and as a CRO executive, he built strong experience in the field of clinical research and health innovations. He joined the company in 2016, and is an Exe

HOCINE MOKHTARI
Technical director

After graduating in computer engineering, he joined the company soon after its creation. He knows very well all the society’s applications. True expert on software development, he always has the right technical.

A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT

64 +

countries
involved

20 000 +

investigational
Centres

3 million +

patients
in database

50 000 +

users
worlwide

telemedicine technologies earth

LATEST NEWSOUR NEWS >

telemedecine technologies news

Clinical Trial Budget: A Guide to Smart Clinical Expense Planning – Webinar

September 30, 2024

29 October 2024 from 10:00AM to 11:30AM (CET) Register Now! Overview Clinical stage is the most expensive stage of drug development. The cost of clinical trials has increased by 100% over the past decade. It is natural, that it should be approached with careful planning and understanding of the rationale behind each item of the […]

READ MORE
telemedecine technologies news

Advancing Safeguards for Innovative Clinical Research

September 30, 2024

Applied Clinical Trials Online As the field of clinical research undergoes rapid evolution, so too must the methodologies employed to safeguard patient participants. Whereas the focus of recent decades was predominantly on developing novel cardiovascular treatments for heart disease, contemporary research increasingly targets innovative therapies for conditions such as Alzheimer’s disease, cancer, and rare disorders. […]

READ MORE
telemedecine technologies news

How AI Can Help Hospitals Overcome Patient Flow Barriers

September 30, 2024

Med City News Artificial intelligence (AI) holds potential to forecast and predict where hospital leaders should direct limited resources such as clinicians, staff, and beds to improve operational efficiency and drive better patient outcomes. Although health systems have seen some much-needed improvement to operating margins in recent quarters, these positive headlines mask a disturbing reality […]

READ MORE